(0.19%) 5 470.63 points
(0.18%) 39 188 points
(0.57%) 17 833 points
(2.17%) $83.31
(-3.77%) $2.50
(0.00%) $2 339.50
(1.33%) $29.63
(-2.41%) $989.70
(-0.14%) $0.932
(-0.12%) $10.66
(0.04%) $0.791
(1.05%) $86.62
0.15% $ 20.00
Live Chart Being Loaded With Signals
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 387 776 |
Średni wolumen | 677 842 |
Kapitalizacja rynkowa | 843.96M |
EPS | $-0.200 ( Q2 | 2023-02-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-20.83 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.103 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Paulsen Erik | Sell | 20 627 | Restricted Stock Units |
2023-04-27 | Paulsen Erik | Sell | 700 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 138 957 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 34 051 | Common Stock |
2023-04-27 | Rempe Stephen J. | Sell | 75 659 | Common Stock |
INSIDER POWER |
---|
-86.84 |
Last 100 transactions |
Buy: 675 433 | Sell: 1 911 221 |
Wolumen Korelacja
Cardiovascular Systems Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cardiovascular Systems Korelacja - Waluta/Towar
Cardiovascular Systems Finanse
Annual | 2022 |
Przychody: | $236.22M |
Zysk brutto: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2022 |
Przychody: | $236.22M |
Zysk brutto: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2021 |
Przychody: | $258.97M |
Zysk brutto: | $197.84M (76.39 %) |
EPS: | $-0.350 |
FY | 2020 |
Przychody: | $236.55M |
Zysk brutto: | $187.79M (79.39 %) |
EPS: | $-0.790 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cardiovascular Systems
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej